Back
Texas Capital Texas Oil Index ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
58
OILT
Texas Capital Texas Oil Index ETF
Last Price:
25.04
Seasonality Move:
--
Sell
22
APLS
Apellis Pharmaceuticals
Last Price:
32.71
Seasonality Move:
18.8%
Buy
58
Texas Capital Texas Oil Index ETF (OILT)
is a Buy
Is Texas Capital Texas Oil Index ETF a Buy, Sell or Hold?
- The current Texas Capital Texas Oil Index ETF [OILT] share price is $25.32. The Score for OILT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- OILT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.72. The Score for APLS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OILT Stock Price Chart
What is Texas Capital Texas Oil Index ETF's stock price today?
-
The Texas Capital Texas Oil Index ETF share price today is $25.32
The current trend is relatively stagnant and OILT is experiencing slight buying pressure.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
OILT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 52.11 | Buy |
| Chaikin Money Flow: | 638 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.32 - 26.18) | Buy |
| Bollinger Bands (100): | (25.43 - 27.61) | Sell |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.09 | Sell |
| Relative Strength Index (14 RSI): | 34.53 | Sell |
| Chaikin Money Flow: | 2311416 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.9 - 40.1) | Sell |
| Bollinger Bands (100): | (36.41 - 42.27) | Sell |
OILT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.63 | Buy |
| 20-day SMA: | 25.06 | Buy |
| 50-day SMA: | 25.85 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 24.86 | Buy |
| 20-day EMA: | 25.01 | Buy |
| 50-day EMA: | 25.63 | Sell |
| 200-day EMA: | 8.56 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.48 | Sell |
| 20-day SMA: | 37.67 | Sell |
| 50-day SMA: | 37.75 | Sell |
| 200-day SMA: | 49.84 | Sell |
| 8-day EMA: | 35.24 | Sell |
| 20-day EMA: | 36.78 | Sell |
| 50-day EMA: | 38.03 | Sell |
| 200-day EMA: | 45.57 | Sell |
Texas Capital Texas Oil Index ETF Earnings Growth & OILT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.32 per share.
Texas Capital Texas Oil Index ETF Technical Analysis
| Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||